KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Invested Capital (2023 - 2025)

Aquestive Therapeutics has reported Return on Invested Capital over the past 3 years, most recently at 0.01% for Q1 2025.

  • For Q1 2025, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM value through Mar 2025 reached 0.01%, changed 0.0%, while the annual FY2024 figure was 0.01%, 1.0% up from the prior year.
  • Return on Invested Capital for Q1 2025 was 0.01% at Aquestive Therapeutics, down from 0.04% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.04% in Q4 2024 and troughed at 0.05% in Q3 2024.
  • A 3-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Invested Capital.
  • On a YoY basis, Return on Invested Capital climbed as much as 4bps in 2024 and fell as far as -5bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.0% in 2023, then surged by 1489bps to 0.04% in 2024, then tumbled by -73bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for AQST at 0.01% in Q1 2025, 0.04% in Q4 2024, and 0.05% in Q3 2024.